We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




GE Acquires Brazil Medical Equipment Maker XPRO

By HospiMedica International staff writers
Posted on 18 Jun 2012
GE Healthcare (GE, Little Chalfont, United Kingdom) has acquired XPRO (Belo Horizonte, Brazil), a manufacturer of interventional X-ray machines, in a bid to expand its presence in Latin America.

The acquisition is the first made by GE in the subcontinent, and is intended to increase the overall presence of the company in the broader emerging markets. More...
XPRO fits into this target with a balanced mix of adequate imaging technology, lowest-cost mechanical solutions (such as the positioner, examination table, and peripherals), and a well-rounded applications suite for interventional segments such as cardiology, peripheral vascular, and neurology. The terms of the transaction were not disclosed.

Upon completion, XPRO will be part of a GE Healthcare business unit called Detection & Guidance Solutions (DGS), a USD 2 billion global business, which is made up of eight separate business segments, currently employing over 1,700 employees. The DGS business distributes products and services in all geographies, and has engineering and manufacturing capability in the US, France, Hungary, India, and China. XPRO will expand DGS' engineering and manufacturing presence into Brazil, and add an additional 132 employees.

“With over 120 vascular systems in the installed base, primarily at private value customer sites, XPRO has become a well-known player in healthcare in Brazil,” said Rogerio Patrus, chief executive for GE Healthcare in Latin America. “This acquisition demonstrates GE Healthcare's commitment to Latin America as an independent, growing region.”

“GE Healthcare Detection & Guidance Solutions and XPRO are highly complementary. Our value products have been strategically developed with our local customers needs in mind and GE is broadly recognized for its capabilities in R&D and distribution,” said Sandro Moraes, President of XPRO. “With GE Healthcare’s proven track record in China and India for improving access to new technologies, we are confident that our combined know-how will reinforce our offering and positioning not only in Brazil but also in other emerging countries globally.”

Related Links:

GE Healthcare
XPRO




Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Warming Cabinet
EC1850BL
New
Needle Guide Disposable Kit
Verza
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: A mechanosensing-based approach offers a potential path to the treatment for cardiac fibrosis (Photo courtesy of Adobe Stock)

Mechanosensing-Based Approach Offers Promising Strategy to Treat Cardiovascular Fibrosis

Cardiac fibrosis, which involves the stiffening and scarring of heart tissue, is a fundamental feature of nearly every type of heart disease, from acute ischemic injuries to genetic cardiomyopathies.... Read more

Surgical Techniques

view channel
Image: The engine-free, nonlinear, flexible, micro-robotic platform leverages AI to optimize GBM treatment (Photo courtesy of Symphony Robotics)

First-Ever MRI-Steerable Micro-Robotics to Revolutionize Glioblastoma Treatment

Glioblastoma Multiforme (GBM) is one of the most aggressive and difficult-to-treat brain cancers. Traditional surgical procedures, such as craniotomies, involve significant invasiveness, requiring large... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.